These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7248763)

  • 1. Chronic lead treatment induces in rat a specific and differential effect on dopamine receptors in different brain areas.
    Lucchi L; Memo M; Airaghi ML; Spano PF; Trabucchi M
    Brain Res; 1981 Jun; 213(2):397-404. PubMed ID: 7248763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M; Battaini F; Spano PF; Trabucchi M
    Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging process affects a single class of dopamine receptors.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
    Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas.
    Govoni S; Memo M; Spano PF; Trabucchi M
    Toxicology; 1979; 12(3):343-9. PubMed ID: 494315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
    Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
    Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.
    Terai M; Usuda S; Kuroiwa I; Noshiro O; Maeno H
    Jpn J Pharmacol; 1983 Aug; 33(4):749-55. PubMed ID: 6138453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
    Jenner P; Marsden CD
    Acta Psychiatr Scand Suppl; 1984; 311():109-23. PubMed ID: 6142587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain.
    Hall H; Köhler C; Gawell L
    Eur J Pharmacol; 1985 May; 111(2):191-9. PubMed ID: 4018125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS.
    Memo M; Govoni S; Carboni E; Trabucchi M; Spano PF
    Pharmacol Res Commun; 1983 Feb; 15(2):191-9. PubMed ID: 6844376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area.
    Pizzi M; Coen E; Memo M; Missale C; Carruba MO; Spano PF
    Neurosci Lett; 1986 Jun; 67(2):159-62. PubMed ID: 2941702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.